Harvard Bioscience, Inc. (HBIO) Reports Q2 Earnings of $0.08

Harvard Bioscience, Inc. (NASDAQ: HBIO) reported Q2 EPS of $0.08, versus $0.08 reported last year. Revenue for the quarter came in at $27.1 million, versus $25.9 million reported last year.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• KULR Technology Group (KULR) Misses Q2 EPS by 39c
• Gemini Space Station, Inc. (GEMI) Misses Q2 EPS by 32c